CVS logo

CVS Health (CVS) Cash and cash equivalents

annual cash & cash equivalents:

$8.59B+$390.00M(+4.76%)
December 31, 2024

Summary

  • As of today (May 20, 2025), CVS annual cash & cash equivalents is $8.59 billion, with the most recent change of +$390.00 million (+4.76%) on December 31, 2024.
  • During the last 3 years, CVS annual cash & cash equivalents has fallen by -$822.00 million (-8.74%).
  • CVS annual cash & cash equivalents is now -33.67% below its all-time high of $12.95 billion, reached on December 31, 2022.

Performance

CVS Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSbalance sheet metrics

quarterly cash & cash equivalents:

$10.08B+$1.49B(+17.35%)
March 31, 2025

Summary

  • As of today (May 20, 2025), CVS quarterly cash & cash equivalents is $10.08 billion, with the most recent change of +$1.49 billion (+17.35%) on March 31, 2025.
  • Over the past year, CVS quarterly cash & cash equivalents has increased by +$275.00 million (+2.81%).
  • CVS quarterly cash & cash equivalents is now -77.00% below its all-time high of $43.81 billion, reached on June 30, 2018.

Performance

CVS quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CVS Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.8%+2.8%
3 y3 years-8.7%+19.4%
5 y5 years+51.1%-0.1%

CVS Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-33.7%+4.8%-41.4%+46.6%
5 y5-year-33.7%+51.1%-41.4%+80.0%
alltimeall time-33.7%>+9999.0%-77.0%>+9999.0%

CVS Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$10.08B(+17.4%)
Dec 2024
$8.59B(+4.8%)
$8.59B(+24.9%)
Sep 2024
-
$6.88B(-45.0%)
Jun 2024
-
$12.51B(+27.6%)
Mar 2024
-
$9.80B(+19.6%)
Dec 2023
$8.20B(-36.7%)
$8.20B(-37.2%)
Sep 2023
-
$13.04B(-5.5%)
Jun 2023
-
$13.81B(-5.5%)
Mar 2023
-
$14.62B(+12.9%)
Dec 2022
$12.95B(+37.6%)
$12.95B(-24.7%)
Sep 2022
-
$17.20B(+41.9%)
Jun 2022
-
$12.12B(+43.5%)
Mar 2022
-
$8.44B(-10.3%)
Dec 2021
$9.41B(+19.8%)
$9.41B(-4.3%)
Sep 2021
-
$9.83B(+38.0%)
Jun 2021
-
$7.12B(+27.2%)
Mar 2021
-
$5.60B(-28.7%)
Dec 2020
$7.85B(+38.2%)
$7.85B(-15.1%)
Sep 2020
-
$9.26B(-37.7%)
Jun 2020
-
$14.87B(+47.5%)
Mar 2020
-
$10.08B(+77.4%)
Dec 2019
$5.68B(+40.0%)
$5.68B(+9.4%)
Sep 2019
-
$5.19B(-14.3%)
Jun 2019
-
$6.06B(+2.8%)
Mar 2019
-
$5.90B(+45.3%)
Dec 2018
$4.06B(+139.3%)
$4.06B(-90.2%)
Sep 2018
-
$41.59B(-5.1%)
Jun 2018
-
$43.81B(+4.3%)
Mar 2018
-
$42.02B(+2377.8%)
Dec 2017
$1.70B(-49.7%)
$1.70B(-31.8%)
Sep 2017
-
$2.48B(+18.7%)
Jun 2017
-
$2.09B(-5.5%)
Mar 2017
-
$2.22B(-34.2%)
Dec 2016
$3.37B(+37.1%)
$3.37B(+54.0%)
Sep 2016
-
$2.19B(+94.2%)
Jun 2016
-
$1.13B(-36.6%)
Mar 2016
-
$1.78B(-27.7%)
Dec 2015
$2.46B(-0.9%)
$2.46B(-14.9%)
Sep 2015
-
$2.89B(+132.3%)
Jun 2015
-
$1.24B(-18.1%)
Mar 2015
-
$1.52B(-38.8%)
Dec 2014
$2.48B(-39.3%)
$2.48B(+119.2%)
Sep 2014
-
$1.13B(-29.8%)
Jun 2014
-
$1.61B(-41.7%)
Mar 2014
-
$2.77B(-32.4%)
Dec 2013
$4.09B(+197.4%)
$4.09B(+171.7%)
Sep 2013
-
$1.50B(+28.2%)
Jun 2013
-
$1.17B(-24.3%)
Mar 2013
-
$1.55B(+12.8%)
Dec 2012
$1.38B(-2.7%)
$1.38B(+11.5%)
Sep 2012
-
$1.23B(-32.4%)
Jun 2012
-
$1.82B(-17.5%)
Mar 2012
-
$2.21B(+56.5%)
Dec 2011
$1.41B(-1.0%)
$1.41B(-17.2%)
Sep 2011
-
$1.71B(-23.4%)
Jun 2011
-
$2.23B(+3.1%)
Mar 2011
-
$2.16B(+51.5%)
Dec 2010
$1.43B(+31.4%)
$1.43B(+28.9%)
Jun 2010
-
$1.11B(+5.7%)
Mar 2010
-
$1.05B(-3.6%)
Dec 2009
$1.09B(-19.7%)
$1.09B(-3.9%)
Sep 2009
-
$1.13B(-7.7%)
Jun 2009
-
$1.23B(+22.8%)
Mar 2009
-
$997.40M(-26.2%)
Dec 2008
$1.35B(+28.0%)
$1.35B(+5.4%)
Sep 2008
-
$1.28B(+108.3%)
Jun 2008
-
$615.70M(-24.7%)
Mar 2008
-
$818.20M(-22.6%)
Dec 2007
$1.06B(+99.1%)
$1.06B(+45.3%)
Sep 2007
-
$727.10M(-10.5%)
Jun 2007
-
$812.30M(+14.3%)
Mar 2007
-
$710.70M(+33.9%)
Dec 2006
$530.70M
$530.70M(+34.5%)
Sep 2006
-
$394.60M(-25.9%)
DateAnnualQuarterly
Jun 2006
-
$532.30M(+37.5%)
Mar 2006
-
$387.10M(-24.6%)
Dec 2005
$513.40M(+30.9%)
$513.40M(+39.4%)
Sep 2005
-
$368.20M(-11.1%)
Jun 2005
-
$414.10M(+27.9%)
Mar 2005
-
$323.80M(-17.5%)
Dec 2004
$392.30M(-53.5%)
$392.30M(+10.7%)
Sep 2004
-
$354.40M(-43.1%)
Jun 2004
-
$622.90M(-4.4%)
Mar 2004
-
$651.50M(-22.7%)
Dec 2003
$843.20M(+20.4%)
$843.20M(+15.9%)
Sep 2003
-
$727.30M(+28.3%)
Jun 2003
-
$566.80M(-12.5%)
Mar 2003
-
$648.10M(-7.5%)
Dec 2002
$700.40M(+196.4%)
$700.40M(+222.3%)
Sep 2002
-
$217.30M(-34.8%)
Jun 2002
-
$333.30M(-26.5%)
Mar 2002
-
$453.50M(+91.9%)
Dec 2001
$236.30M(-29.9%)
$236.30M(-41.9%)
Sep 2001
-
$406.60M(+48.5%)
Jun 2001
-
$273.80M(-8.7%)
Mar 2001
-
$299.80M(-11.1%)
Dec 2000
$337.30M(+46.7%)
$337.30M(+57.0%)
Sep 2000
-
$214.90M(+17.8%)
Jun 2000
-
$182.50M(-22.9%)
Mar 2000
-
$236.60M(+2.9%)
Dec 1999
$230.00M(+27.1%)
$230.00M(+35.4%)
Sep 1999
-
$169.90M(-26.9%)
Jun 1999
-
$232.30M(+69.8%)
Mar 1999
-
$136.80M(-24.4%)
Dec 1998
$181.00M(-6.0%)
$181.00M(+44.3%)
Sep 1998
-
$125.40M(+102.3%)
Jun 1998
-
$62.00M(-44.7%)
Mar 1998
-
$112.20M(-41.7%)
Dec 1997
$192.50M(-59.2%)
$192.50M(+26.7%)
Sep 1997
-
$151.90M(+102.8%)
Jun 1997
-
$74.90M(-77.6%)
Mar 1997
-
$334.60M(-29.1%)
Dec 1996
$471.80M(+264.0%)
$471.80M(+427.2%)
Sep 1996
-
$89.50M(+8.7%)
Jun 1996
-
$82.30M(-8.6%)
Mar 1996
-
$90.00M(-30.6%)
Dec 1995
$129.60M(+10.8%)
$129.60M(+61.8%)
Sep 1995
-
$80.10M(-3.1%)
Jun 1995
-
$82.70M(-6.3%)
Mar 1995
-
$88.30M(-24.5%)
Dec 1994
$117.00M(+44.4%)
$117.00M(+41.1%)
Sep 1994
-
$82.90M(+16.9%)
Jun 1994
-
$70.90M(-37.4%)
Mar 1994
-
$113.20M(+39.8%)
Dec 1993
$81.00M(-44.2%)
$81.00M(-11.7%)
Sep 1993
-
$91.70M(+22.8%)
Jun 1993
-
$74.70M(-13.0%)
Mar 1993
-
$85.90M(-40.8%)
Dec 1992
$145.10M(+84.4%)
$145.10M(+41.8%)
Sep 1992
-
$102.30M(-9.0%)
Jun 1992
-
$112.40M(-19.3%)
Mar 1992
-
$139.20M(+76.9%)
Dec 1991
$78.70M(-29.2%)
$78.70M(+1.7%)
Sep 1991
-
$77.40M(-49.9%)
Jun 1991
-
$154.50M(+14.3%)
Mar 1991
-
$135.20M(+21.7%)
Dec 1990
$111.10M(-69.9%)
$111.10M(+11.1%)
Sep 1990
-
$100.00M(+0.8%)
Jun 1990
-
$99.20M(+31.9%)
Mar 1990
-
$75.20M(-79.6%)
Dec 1989
$368.80M(+23.6%)
$368.80M(+371.0%)
Sep 1989
-
$78.30M(-68.5%)
Jun 1989
-
$248.60M(+273.8%)
Mar 1989
-
$66.50M(-77.7%)
Dec 1988
$298.40M(-12.7%)
$298.40M(-12.7%)
Dec 1987
$341.80M(+4.6%)
$341.80M(+4.6%)
Dec 1986
$326.80M(+7.3%)
$326.80M(+7.3%)
Dec 1985
$304.70M(+62.2%)
$304.70M(+62.2%)
Dec 1984
$187.80M
$187.80M

FAQ

  • What is CVS Health annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for CVS Health?
  • What is CVS Health annual cash & cash equivalents year-on-year change?
  • What is CVS Health quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for CVS Health?
  • What is CVS Health quarterly cash & cash equivalents year-on-year change?

What is CVS Health annual cash & cash equivalents?

The current annual cash & cash equivalents of CVS is $8.59B

What is the all time high annual cash & cash equivalents for CVS Health?

CVS Health all-time high annual cash & cash equivalents is $12.95B

What is CVS Health annual cash & cash equivalents year-on-year change?

Over the past year, CVS annual cash & cash equivalents has changed by +$390.00M (+4.76%)

What is CVS Health quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CVS is $10.08B

What is the all time high quarterly cash & cash equivalents for CVS Health?

CVS Health all-time high quarterly cash & cash equivalents is $43.81B

What is CVS Health quarterly cash & cash equivalents year-on-year change?

Over the past year, CVS quarterly cash & cash equivalents has changed by +$275.00M (+2.81%)
On this page